Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Investigating the Mechanisms of Bisdemethoxycurcumin in Ulcerative Colitis: Network Pharmacology and Experimental Verification.
Molecules ( IF 4.2 ) Pub Date : 2022-12-21 , DOI: 10.3390/molecules28010068 Huihuan Wu 1, 2 , Sha Tu 1 , Zewei Zhuo 1 , Rui Jiang 2 , Ruijie Zeng 1 , Qi Yang 1 , Qizhou Lian 3 , Weihong Sha 1, 2 , Hao Chen 1, 2
Molecules ( IF 4.2 ) Pub Date : 2022-12-21 , DOI: 10.3390/molecules28010068 Huihuan Wu 1, 2 , Sha Tu 1 , Zewei Zhuo 1 , Rui Jiang 2 , Ruijie Zeng 1 , Qi Yang 1 , Qizhou Lian 3 , Weihong Sha 1, 2 , Hao Chen 1, 2
Affiliation
Ulcerative colitis is a chronic inflammatory bowel disorder that is hard to cure once diagnosed. Bisdemethoxycurcumin has shown positive effects on inflammatory diseases. However, the underlying bioactive interaction between bisdemethoxycurcumin and ulcerative colitis is unclear. The objective of this study was to determine the core target and potential mechanism of action of bisdemethoxycurcumin as a therapy for ulcerative colitis. The public databases were used to identify potential targets for bisdemethoxycurcumin and ulcerative colitis. To investigate the potential mechanisms, the protein-protein interaction network, gene ontology analysis, and Kyoto encyclopedia of genes and genomes analysis have been carried out. Subsequently, experimental verification was conducted to confirm the findings. A total of 132 intersecting genes of bisdemethoxycurcumin, as well as ulcerative coli-tis-related targets, were obtained. SRC, EGFR, AKT1, and PIK3R1 were the targets of highest potential, and the PI3K/Akt and MAPK pathways may be essential for the treatment of ulcerative colitis by bisdemethoxycurcumin. Molecular docking demonstrated that bisdemethoxycurcumin combined well with SRC, EGFR, PIK3R1, and AKT1. Moreover, the in vitro experiments suggested that bisdemethoxycurcumin might reduce LPS-induced pro-inflammatory cytokines levels in RAW264.7 cells by suppressing PI3K/Akt and MAPK pathways. Our study provided a comprehensive overview of the potential targets and molecular mechanism of bisdemethoxycurcumin against ulcerative colitis. Furthermore, it also provided a theoretical basis for the clinical treatment of ulcerative colitis, as well as compelling evidence for further study on the mechanism of bisdemethoxycurcumin in the treatment of ulcerative colitis.
中文翻译：
研究双去甲氧基姜黄素在溃疡性结肠炎中的作用机制：网络药理学和实验验证。
溃疡性结肠炎是一种慢性炎症性肠病，一旦确诊就很难治愈。双去甲氧基姜黄素对炎症性疾病有积极作用。然而，双去甲氧基姜黄素与溃疡性结肠炎之间潜在的生物活性相互作用尚不清楚。本研究的目的是确定双去甲氧基姜黄素治疗溃疡性结肠炎的核心靶点和潜在作用机制。公共数据库用于确定双去甲氧基姜黄素和溃疡性结肠炎的潜在靶标。为了研究潜在的机制，已经进行了蛋白质-蛋白质相互作用网络、基因本体论分析以及京都基因和基因组百科全书分析。随后，进行了实验验证以证实该发现。共获得了 132 个双去甲氧基姜黄素的交叉基因，以及溃疡性结肠炎相关靶点。SRC、EGFR、AKT1 和 PIK3R1 是最具潜力的靶标，PI3K/Akt 和 MAPK 通路可能对双去甲氧基姜黄素治疗溃疡性结肠炎至关重要。分子对接表明双去甲氧基姜黄素与 SRC、EGFR、PIK3R1 和 AKT1 结合良好。此外，体外实验表明，双去甲氧基姜黄素可能通过抑制 PI3K/Akt 和 MAPK 通路来降低 RAW264.7 细胞中 LPS 诱导的促炎细胞因子水平。我们的研究全面概述了双去甲氧基姜黄素抗溃疡性结肠炎的潜在靶点和分子机制。此外，还为溃疡性结肠炎的临床治疗提供了理论依据，
更新日期：2022-12-21
中文翻译：
研究双去甲氧基姜黄素在溃疡性结肠炎中的作用机制：网络药理学和实验验证。
溃疡性结肠炎是一种慢性炎症性肠病，一旦确诊就很难治愈。双去甲氧基姜黄素对炎症性疾病有积极作用。然而，双去甲氧基姜黄素与溃疡性结肠炎之间潜在的生物活性相互作用尚不清楚。本研究的目的是确定双去甲氧基姜黄素治疗溃疡性结肠炎的核心靶点和潜在作用机制。公共数据库用于确定双去甲氧基姜黄素和溃疡性结肠炎的潜在靶标。为了研究潜在的机制，已经进行了蛋白质-蛋白质相互作用网络、基因本体论分析以及京都基因和基因组百科全书分析。随后，进行了实验验证以证实该发现。共获得了 132 个双去甲氧基姜黄素的交叉基因，以及溃疡性结肠炎相关靶点。SRC、EGFR、AKT1 和 PIK3R1 是最具潜力的靶标，PI3K/Akt 和 MAPK 通路可能对双去甲氧基姜黄素治疗溃疡性结肠炎至关重要。分子对接表明双去甲氧基姜黄素与 SRC、EGFR、PIK3R1 和 AKT1 结合良好。此外，体外实验表明，双去甲氧基姜黄素可能通过抑制 PI3K/Akt 和 MAPK 通路来降低 RAW264.7 细胞中 LPS 诱导的促炎细胞因子水平。我们的研究全面概述了双去甲氧基姜黄素抗溃疡性结肠炎的潜在靶点和分子机制。此外，还为溃疡性结肠炎的临床治疗提供了理论依据，
京公网安备 11010802027423号